Literature DB >> 19870953

SYMPTOMATIC HERPES, A SEQUELA OF ARTIFICIALLY INDUCED FEVER : INCIDENCE AND C ASPECTS; RECOVERY OF A VIRUS FROM HERPETIC VESICLES, AND COMPARISON WITH A K STRAIN OF HERPES VIRUS.

S L Warren1, C M Carpenter, R A Boak.   

Abstract

1. Symptomatic herpes occurred in 190 (46.2 per cent) of 411 patients treated with fever induced by physical methods. 2. Herpes recurred in only 7, or 5.3 per cent, of 131 patients given subsequent fever treatments, suggesting that some immunity develops with the first attack. 3. An acute encephalitis-like syndrome of short duration and without sequelae developed in a group of patients with severe herpes following fever therapy. 4. A filter-passing virus, recovered from herpetic vesicles on patients treated with artificially induced fever, produced a fatal encephalitis in rabbits when inoculated intracerebrally and by corneal scarification. Intranuclear inclusion bodies were observed in corneal epithelial cells and in motor ganglion cells of the brain similar to those observed in rabbits injected with known strains of herpes virus. 5. Four strains of virus that had been recovered from herpetic vesicles appearing on patients subsequent to artificially induced fever were shown by cross-protection tests on rabbits to be immunologically related to the Frank strain of herpes virus.

Entities:  

Year:  1940        PMID: 19870953      PMCID: PMC2135070          DOI: 10.1084/jem.71.2.155

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  10 in total

Review 1.  Persistence in herpes simplex virus infections.

Authors:  M Longson
Journal:  Postgrad Med J       Date:  1978-09       Impact factor: 2.401

2.  Nature and duration of growth factor signaling through receptor tyrosine kinases regulates HSV-1 latency in neurons.

Authors:  Vladimir Camarena; Mariko Kobayashi; Ju Youn Kim; Pamela Roehm; Rosalia Perez; James Gardner; Angus C Wilson; Ian Mohr; Moses V Chao
Journal:  Cell Host Microbe       Date:  2010-10-21       Impact factor: 21.023

3.  Early childhood stress is associated with elevated antibody levels to herpes simplex virus type 1.

Authors:  Elizabeth A Shirtcliff; Christopher L Coe; Seth D Pollak
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-02       Impact factor: 11.205

4.  Heat shock-induced reactivation of herpes simplex virus type 1 in latently infected mouse trigeminal ganglion cells in dissociated culture.

Authors:  A Moriya; A Yoshiki; M Kita; S Fushiki; J Imanishi
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

5.  The role of nerve growth factor in modulating herpes simplex virus reactivation in vivo.

Authors:  K A Laycock; R H Brady; S F Lee; P A Osborne; E M Johnson; J S Pepose
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-07       Impact factor: 3.117

6.  THE THERMAL INACTIVATION TIME AT 41.5 degrees C. OF THREE STRAINS OF HERPES SIMPLEX VIRUS.

Authors:  R A Boak; C M Carpenter; S L Warren
Journal:  J Exp Med       Date:  1940-01-31       Impact factor: 14.307

7.  Neurotrophic Factors NGF, GDNF and NTN Selectively Modulate HSV1 and HSV2 Lytic Infection and Reactivation in Primary Adult Sensory and Autonomic Neurons.

Authors:  Andy A Yanez; Telvin Harrell; Heather J Sriranganathan; Angela M Ives; Andrea S Bertke
Journal:  Pathogens       Date:  2017-02-07

8.  Disseminated zoster in an adult patient with extensive burns: a case report.

Authors:  Yoshitaka Kubota; Kentaro Kosaka; Toshinori Hokazono; Yoshihisa Yamaji; Takafumi Tezuka; Shinsuke Akita; Motone Kuriyama; Nobuyuki Mitsukawa
Journal:  Virol J       Date:  2019-05-23       Impact factor: 4.099

9.  Resolution of herpes simplex virus reactivation in vivo results in neuronal destruction.

Authors:  Jessica R Doll; Kasper Hoebe; Richard L Thompson; Nancy M Sawtell
Journal:  PLoS Pathog       Date:  2020-03-05       Impact factor: 6.823

10.  Herpetic Keratitis and Corneal Endothelitis Following COVID-19 Vaccination: A Case Series.

Authors:  Hassan Alkwikbi; Mohammed Alenazi; Wafi Alanazi; Shahad Alruwaili
Journal:  Cureus       Date:  2022-01-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.